These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

922 related items for PubMed ID: 28865493

  • 1. High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study.
    Takeuchi T, Miyasaka N, Inui T, Yano T, Yoshinari T, Abe T, Koike T.
    Arthritis Res Ther; 2017 Sep 02; 19(1):194. PubMed ID: 28865493
    [Abstract] [Full Text] [Related]

  • 2. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F.
    Ann Rheum Dis; 2005 Feb 02; 64(2):299-302. PubMed ID: 15166003
    [Abstract] [Full Text] [Related]

  • 3. Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.
    Bruns A, Nicaise-Roland P, Hayem G, Palazzo E, Dieudé P, Grootenboer-Mignot S, Chollet-Martin S, Meyer O.
    Joint Bone Spine; 2009 May 02; 76(3):248-53. PubMed ID: 19208451
    [Abstract] [Full Text] [Related]

  • 4. Impact of treatment with infliximab on anticyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis.
    Ahmed MM, Mubashir E, Wolf RE, Hayat S, Hall V, Shi R, Berney SM.
    South Med J; 2006 Nov 02; 99(11):1209-15. PubMed ID: 17195414
    [Abstract] [Full Text] [Related]

  • 5. An exploratory study to determine whether infliximab modifies levels of rheumatoid factor and antibodies to cyclic citrullinated peptides in rheumatoid arthritis patients.
    Martínez-Estupiñán L, Hernández-Flórez D, Janta I, Ovalles-Bonilla JG, Nieto JC, González-Fernández CM, Del Río T, Monteagudo I, López-Longo FJ, Naredo E, Valor L.
    Clin Exp Rheumatol; 2018 Nov 02; 36(1):88-93. PubMed ID: 28850020
    [Abstract] [Full Text] [Related]

  • 6. Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement.
    Alessandri C, Bombardieri M, Papa N, Cinquini M, Magrini L, Tincani A, Valesini G.
    Ann Rheum Dis; 2004 Oct 02; 63(10):1218-21. PubMed ID: 15361374
    [Abstract] [Full Text] [Related]

  • 7. [Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers].
    Benucci M, Turchini S, Parrochi P, Boccaccini P, Manetti R, Cammelli E, Manfredi M.
    Recenti Prog Med; 2006 Mar 02; 97(3):134-9. PubMed ID: 16700418
    [Abstract] [Full Text] [Related]

  • 8. Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment.
    Caramaschi P, Biasi D, Tonolli E, Pieropan S, Martinelli N, Carletto A, Volpe A, Bambara LM.
    Rheumatol Int; 2005 Nov 02; 26(1):58-62. PubMed ID: 15726373
    [Abstract] [Full Text] [Related]

  • 9. The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.
    Chen HA, Lin KC, Chen CH, Liao HT, Wang HP, Chang HN, Tsai CY, Chou CT.
    Ann Rheum Dis; 2006 Jan 02; 65(1):35-9. PubMed ID: 15975966
    [Abstract] [Full Text] [Related]

  • 10. Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study.
    Berendsen MLT, van Maaren MC, Arts EEA, den Broeder AA, Popa CD, Fransen J.
    J Rheumatol; 2017 Sep 02; 44(9):1325-1330. PubMed ID: 28668802
    [Abstract] [Full Text] [Related]

  • 11. Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study.
    Atzeni F, Sarzi-Puttini P, Dell' Acqua D, de Portu S, Cecchini G, Cruini C, Carrabba M, Meroni PL.
    Arthritis Res Ther; 2006 Sep 02; 8(1):R3. PubMed ID: 16356192
    [Abstract] [Full Text] [Related]

  • 12. Influence of rheumatoid factor on serum drug levels of TNF inhibitors with different structures in rheumatoid arthritis.
    Martínez-Feito A, Plasencia-Rodríguez C, Novella-Navarro M, Gehin JE, Hernández-Breijo B, Brenis CM, Villalba-Yllán A, Fernández E, Monjo-Henry I, Pascual-Salcedo D, Nozal P, Balsa A.
    Clin Exp Rheumatol; 2024 May 02; 42(5):999-1005. PubMed ID: 38197184
    [Abstract] [Full Text] [Related]

  • 13. IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.
    Vis M, Bos WH, Wolbink G, Voskuyl AE, Twisk JW, Van de Stadt R, Hamann D, Dijkmans BA, Lems WF.
    J Rheumatol; 2008 Mar 02; 35(3):425-8. PubMed ID: 18322974
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.
    Meyer PWA, Ally MTM, Hodkinson B, Anderson R, Tikly M.
    Rheumatol Int; 2018 Jun 02; 38(6):993-1001. PubMed ID: 29713794
    [Abstract] [Full Text] [Related]

  • 15. Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort.
    Mouterde G, Lukas C, Goupille P, Flipo RM, Rincheval N, Daurès JP, Combe B.
    J Rheumatol; 2014 Aug 02; 41(8):1614-22. PubMed ID: 25028372
    [Abstract] [Full Text] [Related]

  • 16. The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis.
    Ahmadi H, Jamshidi AR, Mahmoudi M, Cuzzocrea S, Fattahi MJ, Barati A, Rehm BHA, Matsuo H, Mirshafiey A.
    Curr Drug Discov Technol; 2017 Aug 02; 14(3):206-214. PubMed ID: 28325148
    [Abstract] [Full Text] [Related]

  • 17. The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study.
    Klaasen R, Cantaert T, Wijbrandts CA, Teitsma C, Gerlag DM, Out TA, de Nooijer MJ, Baeten D, Tak PP.
    Rheumatology (Oxford); 2011 Aug 02; 50(8):1487-93. PubMed ID: 21454308
    [Abstract] [Full Text] [Related]

  • 18. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
    Shovman O, Gilburd B, Zandman-Goddard G, Sherer Y, Orbach H, Gerli R, Shoenfeld Y.
    Clin Dev Immunol; 2005 Sep 02; 12(3):197-202. PubMed ID: 16295525
    [Abstract] [Full Text] [Related]

  • 19. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.
    Potter C, Hyrich KL, Tracey A, Lunt M, Plant D, Symmons DP, Thomson W, Worthington J, Emery P, Morgan AW, Wilson AG, Isaacs J, Barton A, BRAGGSS.
    Ann Rheum Dis; 2009 Jan 02; 68(1):69-74. PubMed ID: 18375541
    [Abstract] [Full Text] [Related]

  • 20. Rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies with hepatitis B and hepatitis C infection: Review.
    Zengin O, Yıldız H, Demir ZH, Dağ MS, Aydınlı M, Onat AM, Kısacık B.
    Adv Clin Exp Med; 2017 Sep 02; 26(6):987-990. PubMed ID: 29068601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.